Atara Biotherapeutics, Inc (ATRA) News

Latest headlines that mention ATRA, newest first · each headline opens the original publisher

ATRA quote

Last price: $8.35
Day change: -2.79%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

ATRA headlines

latest coverage

Not much coverage yet. ATRA has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 1mo ago

Atara Biotherapeutics director Brian Cherry buys nearly $1m in shares

General T3ATRA

Investing.com 5mo ago

Atara Biotherapeutics CEO AnhCo Nguyen sells $47,844 in stock

General T3ATRA

Investing.com 5mo ago

Form 13D/A Atara Biotherapeutics For: 14 May

General T3ATRA

Investing.com 5mo ago

Form 424B5 Atara Biotherapeutics Inc For: 12 May

General T3ATRA

Seeking Alpha 5mo ago

Atara Biotherapeutics GAAP EPS of -$0.29 misses by $0.04, revenue of $0.52M misses by $1.65M

Earnings T2ATRA

Investing.com 5mo ago

Form 13D/A Atara Biotherapeutics For: 11 May

General T3ATRA

Investing.com 5mo ago

Atara biotherapeutics director James Huang sells $3.16m in stock

General T3ATRA

Seeking Alpha 5mo ago

Atara surges after FDA meeting on cell therapy

General T2ATRA

ATRA news alerts

Get an alert by email or push when a new headline mentions ATRA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.